Capstone Investment Advisors, LLC Amgen Inc Call Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $835,326 - $910,926	2,700 Added 12.05%	25,100 $8.09 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.89 Million - $2.3 Million	7,200 Added 47.37%	22,400 $7 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $2.45 Million - $2.95 Million	-9,100 Reduced 37.45%	15,200 $4.32 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $3.38 Million - $3.81 Million	13,200 Added 118.92%	24,300 $7 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $1.09 Million - $1.36 Million	5,000 Added 81.97%	11,100 $2.98 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $471,394 - $557,414	2,200 Added 56.41%	6,100 $1.35 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $1.76 Million - $2.15 Million	-7,800 Reduced 66.67%	3,900 $942,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $206,127 - $261,909	-900 Reduced 7.14%	11,700 $3.07 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $516,258 - $582,245	-2,300 Reduced 15.44%	12,600 $2.84 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $8.26 Million - $9.19 Million	-35,800 Reduced 70.61%	14,900 $3.63 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $7.52 Million - $8.32 Million	-34,300 Reduced 40.35%	50,700 $12.3 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $596,640 - $682,800	3,000 Added 3.66%	85,000 $19.1 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.7 Million - $1.99 Million	-8,000 Reduced 8.89%	82,000 $17.4 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $700,740 - $777,420	-3,000 Reduced 3.23%	90,000 $21.9 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $3.88 Million - $4.53 Million	17,500 Added 23.18%	93,000 $23.1 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $2.14 Million - $2.55 Million	9,900 Added 15.09%	75,500 $17.4 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $5.94 Million - $6.6 Million	25,300 Added 62.78%	65,600 $16.7 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $7.02 Million - $8.62 Million	35,500 Added 739.58%	40,300 $9.51 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $8.78 Million - $11.6 Million	-48,200 Reduced 90.94%	4,800 $973,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $832,524 - $1.07 Million	-4,400 Reduced 7.67%	53,000 $12.8 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2.75 Million - $3.3 Million	15,800 Added 37.98%	57,400 $11.1 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $750,150 - $879,345	-4,500 Reduced 9.76%	41,600 $7.67 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $4.32 Million - $4.87 Million	23,900 Added 107.66%	46,100 $8.76 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $267,600 - $312,375	1,500 Added 7.25%	22,200 $4.32 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $3.39 Million - $3.82 Million	18,300 Added 762.5%	20,700 $4.29 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $398,520 - $447,624	2,400 New	2,400 $443,000

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

407M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account